drugset / Trial / NCT01512004
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this Phase III study is to evaluate the efficacy and safety of Propiverine Hydrochloride Extended-Release Capsule in the treatment of overactive bladder in Chinese population with urgent micturition, frequent micturition and/or urge urinary incontinence.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-01
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propiverine | Small molecule | 30 mg | Oral |
| Comparator | Tolterodine | Small molecule | 4 mg | Oral |